Suppr超能文献

经姑息性腹腔镜胃空肠吻合术后,对伴有胃出口梗阻和远处转移的不可切除胃癌患者实施腹腔内和 FOLFOX 化疗的疗效:病例报告。

Unresectable gastric cancer with gastric outlet obstruction and distant metastasis responding to intraperitoneal and folfox chemotherapy after palliative laparoscopic gastrojejunostomy: report of a case.

机构信息

Department of Surgery, Chung-Ang University College of Medicine, Seoul, Korea.

出版信息

World J Surg Oncol. 2010 Dec 20;8:109. doi: 10.1186/1477-7819-8-109.

Abstract

BACKGROUND

Gastric outlet obstruction (GOO) caused by unresectable gastric cancer is a challenging aspect of patient care. There have been no reports involving patients with obstructing gastric cancer and several incurable factors curatively treated by multimodal treatments.

CASE PRESENTATION

We report a case of 55-year-old man who was diagnosed with a poorly differentiated adenocarcinoma in the pre-pyloric antrum with GOO by gastroscopy. An abdominal computed tomography (CT) scan revealed thickening of the gastric wall and adjacent fat infiltration, and a large amount of food in the stomach suggesting a passage disturbance, enlarged lymph nodes along the common hepatic and left gastric arteries, and multiple hepatic metastases. The serum carcinoembryonic antigen (CEA) level was 343 ng/ml and the carbohydrate antigen (CA) 19-9 level was within normal limits. The patient underwent a laparoscopic gastrojejunostomy for palliation of the GOO. On the 3rd and 12th days after surgery, he received intraperitoneal chemotherapy with 40 mg of docetaxel and 150 mg of carboplatin. Simultaneously, combined chemotherapy with 85 mg/m2 of oxaliplatin for the 1st day and 600 mg/m2 of 5-FU for 2 days (FOLFOX regimen) was administered from the 8th post-operative day. After completion of nine courses of FOLFOX, the patient achieved a complete response (CR) with complete disappearance of the primary tumor and the metastatic foci. He underwent a radical subtotal gastrectomy with D3 lymph node dissection 4 months after the initial palliative surgery. The pathologic results revealed no residual primary tumor and no lymph node metastasis in 43 dissected lymph nodes. He has maintained a CR for 18 months since the last operation.

CONCLUSION

Combination chemotherapy with systemic and intraperitoneal chemotherapy following laparoscopic bypass surgery showed marked efficacy in the treatment for unresectable advanced gastric cancer with GOO.

摘要

背景

无法切除的胃癌引起的胃出口梗阻(GOO)是患者治疗的一个具有挑战性的方面。目前尚无涉及伴有梗阻性胃癌和多种不可治愈因素的患者经多模式治疗治愈的报道。

病例介绍

我们报告了一例 55 岁男性病例,患者因 GOO 行胃镜检查诊断为胃前壁小弯侧低分化腺癌。腹部 CT 扫描显示胃壁增厚伴邻近脂肪浸润,胃内大量食物提示通道受阻,沿肝总动脉和胃左动脉分布的淋巴结肿大,以及多发肝转移。血清癌胚抗原(CEA)水平为 343ng/ml,糖类抗原(CA)19-9 水平正常。患者接受腹腔镜胃空肠吻合术姑息治疗 GOO。术后第 3 和 12 天,患者接受腹腔内化疗,给予 40mg 多西他赛和 150mg 卡铂。同时,从术后第 8 天开始,联合奥沙利铂 85mg/m2 第 1 天和 5-FU 600mg/m2 第 2 天(FOLFOX 方案)化疗。完成 9 个疗程的 FOLFOX 后,患者原发肿瘤和转移灶完全消失,达到完全缓解(CR)。初始姑息手术后 4 个月,患者接受了根治性胃大部切除术和 D3 淋巴结清扫术。病理结果显示,43 个清扫淋巴结中未见残留原发肿瘤和淋巴结转移。自最后一次手术以来,患者已维持 CR 达 18 个月。

结论

腹腔镜旁路手术后联合全身和腹腔内化疗的联合化疗对伴有 GOO 的不可切除晚期胃癌显示出显著疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91a8/3014937/78a397898160/1477-7819-8-109-1.jpg

相似文献

2
Staged laparoscopic management of locally advanced gastric cancer with outlet obstruction.
J Surg Oncol. 2021 May;123 Suppl 1:S8-S14. doi: 10.1002/jso.26342. Epub 2021 Apr 5.
5
7
Laparoscopic-assisted stomach-partitioning gastrojejunostomy for the palliation of gastric outlet obstruction from antral gastric cancer.
Surg Laparosc Endosc Percutan Tech. 2009 Jun;19(3):e76-9. doi: 10.1097/SLE.0B013E3181A039E1.

引用本文的文献

1
Development of a Signature Based on Eight Metastatic-Related Genes for Prognosis of GC Patients.
Mol Biotechnol. 2023 Nov;65(11):1796-1808. doi: 10.1007/s12033-023-00671-9. Epub 2023 Feb 15.
4
Clinical utility of perioperative staging laparoscopy for advanced gastric cancer.
World J Surg Oncol. 2014 Nov 18;12:350. doi: 10.1186/1477-7819-12-350.
6
Carcinoma stomach: unwanted chemotherapeutic success: a case vignette.
J Clin Diagn Res. 2013 Dec;7(12):3016-7. doi: 10.7860/JCDR/2013/6777.3834. Epub 2013 Dec 15.

本文引用的文献

2
Induction chemotherapy with S-1 plus cisplatin followed by surgery for treatment of gastric cancer with peritoneal dissemination.
Ann Surg Oncol. 2009 Dec;16(12):3227-36. doi: 10.1245/s10434-009-0706-z. Epub 2009 Sep 24.
6
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).
Eur J Cancer. 2009 Jan;45(2):228-47. doi: 10.1016/j.ejca.2008.10.026.
8
S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial.
Lancet Oncol. 2008 Mar;9(3):215-21. doi: 10.1016/S1470-2045(08)70035-4. Epub 2008 Feb 20.
9
10
Response to neoadjuvant chemotherapy and effects of tumor regression in gastric cancer.
Eur J Surg Oncol. 2006 Dec;32(10):1105-9. doi: 10.1016/j.ejso.2006.07.009. Epub 2006 Aug 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验